Early steroid treatment for drug-induced acute interstitial nephritis
Steven G Coca and Mark A Perazella*
Correspondence *Section of Nephrology, Yale University School of Medicine, FMP 107, 330 Cedar Street, New Haven, CT 60520-8029, USA
Email mark.perazella@yale.edu
This article has no abstract so we have provided the first paragraph of the full text.
AIN accounts for 2–10% of all cases of acute kidney injury and approximately 10–27% of all cases of unexplained renal failure. Steroids should be an effective treatment for AIN in humans, as the condition results from cell-mediated immunity. Unfortunately, no randomized controlled trials or prospective studies of steroids in AIN have been performed, which leaves us with only mixed data from retrospective analyses.1, 2, 3, 4
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
